Geron Corporation’s First Human Embryonic Stem Cell Trial at Shepherd Center

Bloomberg -- Geron Corp. used a therapy made from stem cells taken from human embryos to treat a patient paralyzed by a spinal-cord injury in the first U.S.-authorized test of the technology.